NCT00614393(b)_3A | R Documentation |
Kaplan-Meier digitized data from NCT00614393(b), figure 3A (PMID 26405092). A reported sample size of 344 for a primary endpoint of PFS,OS in colorectal cancer.
`NCT00614393(b)_3A`
A data frame of 228 observations and 3 variables:
time | event time (in months) | |
event | PFS event indicator (0 : no event, 1 : event) |
|
arm | treatment arms (armb, armc) | |
Sclafani F, Kim TY, Cunningham D, et al. A Randomized Phase II/III Study of Dalotuzumab in Combination With Cetuximab and Irinotecan in Chemorefractory, KRAS Wild-Type, Metastatic Colorectal Cancer. J Natl Cancer Inst 2015; 107: djv258.
summary(`NCT00614393(b)_3A`)
kmplot(`NCT00614393(b)_3A`)
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.